H.R. 4531
Reauthorizes addiction prevention and treatment programs and makes Medicaid coverage of addiction medication permanent.
Medium confidence
AI scores averaged: +1 from typesafe:jev-1.13.0, +2 from claude-opus-5-5. Compare the models
Places illicit xylazine on the controlled substances schedule.
Medium confidence
AI score: +1 from claude-opus-5-5. Compare the models
TypeSafe: affects p=0.87, effect -1.23 (conf 0.75)
High confidence
AI score: −1 from typesafe:jev-1.13.0. Compare the models
Support for Patients and Communities Reauthorization Act This bill reauthorizes through FY2028 and modifies various grants, programs, and activities that address substance use and misuse. This includes reauthorizing (1) data collection, education, and surveillance activities; (2) grants and other support for substance use disorder prevention, treatment, and recovery; (3) student loan repayment and other programs for the substance use disorder workforce; and (4) programs for addressing trauma, particularly for children, youth, and their families. Generally, the modifications expand programs. Additionally, the bill modifies provisions related to the scheduling of controlled substances, including by incorporating illicit xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer) into schedule III of the Controlled Substances Act. Further, the bill makes permanent a requirement that Medicaid programs cover medication-assisted treatment for individuals with substance use disorders.
Summary by the Congressional Research Service, passed house version.
On Motion to Suspend the Rules and Pass, as Amended, Dec 12, 2023 · Passed